- Home
- Publications
- Publication Search
- Publication Details
Title
Brain Tumor Vaccines
Authors
Keywords
Brain tumor vaccines, Brain tumor immunotherapy, Dendritic cell vaccines, Peptide vaccines
Journal
NEUROSURGERY CLINICS OF NORTH AMERICA
Volume 32, Issue 2, Pages 225-234
Publisher
Elsevier BV
Online
2021-03-27
DOI
10.1016/j.nec.2021.01.003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Once, Twice, Three Times a Finding: Reproducibility of Dendritic Cell Vaccine Trials Targeting Cytomegalovirus in Glioblastoma
- (2020) Kristen A Batich et al. CLINICAL CANCER RESEARCH
- HPV Vaccination and the Risk of Invasive Cervical Cancer
- (2020) Jiayao Lei et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Double-Blind Placebo-Controlled Phase 2 Trial Of Dendritic Cell Vaccine ICT-107 In Newly Diagnosed Patients With Glioblastoma
- (2019) Patrick Y. Wen et al. CLINICAL CANCER RESEARCH
- Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development
- (2019) Juan Huang et al. Frontiers in Oncology
- Engineering dendritic cell vaccines to improve cancer immunotherapy
- (2019) Caleb R. Perez et al. Nature Communications
- T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma
- (2018) Karolina Woroniecka et al. CLINICAL CANCER RESEARCH
- First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
- (2018) Linda M. Liau et al. Journal of Translational Medicine
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Phase 2 trial of SL-701 in relapsed/refractory (r/r) glioblastoma (GBM): Correlation of immune response with longer-term survival.
- (2018) David M. Peereboom et al. JOURNAL OF CLINICAL ONCOLOGY
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
- (2018) Derin B. Keskin et al. NATURE
- ATIM-41. PHASE II TRIAL OF A SURVIVIN VACCINE (SurVaxM) For Newly Diagnosed Glioblastoma
- (2018) Manmeet Ahluwalia et al. NEURO-ONCOLOGY
- ATIM-14. ALLIANCE A071101: A PHASE II RANDOMIZED TRIAL COMPARING THE EFFICACY OF HEAT SHOCK PROTEIN PEPTIDE COMPLEX-96 (HSPPC-96) VACCINE GIVEN WITH BEVACIZUMAB VERSUS BEVACIZUMAB ALONE IN THE TREATMENT OF SURGICALLY RESECTABLE RECURRENT GLIOBLASTOMA
- (2017) Orin Bloch et al. NEURO-ONCOLOGY
- Immunotherapies for malignant glioma
- (2017) Vassiliki A. Boussiotis et al. ONCOGENE
- K27M-mutant histone-3 as a novel target for glioma immunotherapy
- (2017) Katharina Ochs et al. OncoImmunology
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma
- (2016) Robert A. Fenstermaker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Glioblastoma vaccine therapy disappointment in Phase III trial
- (2016) Hemi Malkki Nature Reviews Neurology
- Therapeutic cancer vaccines
- (2015) Cornelis J.M. Melief et al. JOURNAL OF CLINICAL INVESTIGATION
- Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients
- (2015) Duane A. Mitchell et al. NATURE
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study
- (2015) J. Schuster et al. NEURO-ONCOLOGY
- Immunosuppressive mechanisms in glioblastoma: Fig. 1.
- (2015) Edjah K. Nduom et al. NEURO-ONCOLOGY
- Outcomes of the ACT III Study
- (2015) Benjamin M. Zussman et al. NEUROSURGERY
- Vaccines for the 21st century
- (2014) I. Delany et al. EMBO Molecular Medicine
- A vaccine targeting mutant IDH1 induces antitumour immunity
- (2014) Theresa Schumacher et al. NATURE
- The epidemiology of glioma in adults: a "state of the science" review
- (2014) Q. T. Ostrom et al. NEURO-ONCOLOGY
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
- (2013) P. A. Ott et al. CLINICAL CANCER RESEARCH
- Heat-shock proteins as dendritic cell-targeting vaccines - getting warmer
- (2013) Shaun McNulty et al. IMMUNOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical Opportunities
- (2013) R. A. Cairns et al. Cancer Discovery
- Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
- (2012) Surasak Phuphanich et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Next-generation peptide vaccines for advanced cancer
- (2012) Akira Yamada et al. CANCER SCIENCE
- Individual Patient-Specific Immunity against High-Grade Glioma after Vaccination with Autologous Tumor Derived Peptides Bound to the 96 KD Chaperone Protein
- (2012) C. A. Crane et al. CLINICAL CANCER RESEARCH
- Therapeutic Cancer Vaccines: Current Status and Moving Forward
- (2012) J. Schlom JNCI-Journal of the National Cancer Institute
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
- (2012) Jeremy Schwartzentruber et al. NATURE
- A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction
- (2011) D. T. Le et al. CLINICAL CANCER RESEARCH
- Immunological mechanisms of vaccination
- (2011) Bali Pulendran et al. NATURE IMMUNOLOGY
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
- (2010) Maria E. Figueroa et al. CANCER CELL
- Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma
- (2010) Omar Eton et al. Journal of Translational Medicine
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme
- (2009) J. H. Sampson et al. MOLECULAR CANCER THERAPEUTICS
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vaccine: clinical findings
- (2008) E Jonasch et al. BRITISH JOURNAL OF CANCER
- Phase III Comparison of Vitespen, an Autologous Tumor-Derived Heat Shock Protein gp96 Peptide Complex Vaccine, With Physician's Choice of Treatment for Stage IV Melanoma: The C-100-21 Study Group
- (2008) Alessandro Testori et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytomegalovirus Immunity after Vaccination with Autologous Glioblastoma Lysate
- (2008) Robert M. Prins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
- (2007) Duane A. Mitchell et al. NEURO-ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now